Antifibrotic and molecular aspects of rifaximin in alcoholic liver disease: study protocol for a randomized controlled trial

BACKGROUND: Alcoholic liver disease is the leading cause of cirrhosis worldwide. Due to an increase in alcohol overuse, alcoholic liver disease has become an increased burden on health care systems. Abstinence from alcohol remains the cornerstone of alcoholic liver disease treatment; however, this a...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Trials
Main Authors: Madsen, Bjørn Stæhr, Trebicka, Jonel, Thiele, Maja, Israelsen, Mads, Arumugan, Manimozhiyan, Havelund, Troels, Krag, Aleksander
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2018
Fag:
Study Protocol
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5828001/
https://ncbi.nlm.nih.gov/pubmed/29482588
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-018-2523-9
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker